We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

52 similar At Market Issuance Sales Agreement contracts by Peregrine Pharmaceuticals Inc, Aeterna Zentaris Inc., GreenHunter Energy, Inc., others

GERON CORPORATION Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 28th, 2015 • Geron Corp • Pharmaceutical preparations • New York

Geron Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 7th, 2015 • Peregrine Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • April 10th, 2015 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:

REXAHN PHARMACEUTICALS, INC.
At Market Issuance Sales Agreement • March 16th, 2015 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:

ANWORTH MORTGAGE ASSET CORPORATION Common Stock (par value $0.01 per share) (par value $0.01 per share) (par value $0.01 per share) AT MARKET ISSUANCE SALES AGREEMENT
At Market Issuance Sales Agreement • March 6th, 2015 • Anworth Mortgage Asset Corp • Real estate investment trusts • New York

ANWORTH MORTGAGE ASSET CORPORATION, a Maryland corporation (the “Company”), and ANWORTH MANAGEMENT LLC, a Delaware limited liability company (the “Manager”), confirm their agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

ROCK CREEK PHARMACEUTICALS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • December 15th, 2014 • Rock Creek Pharmaceuticals, Inc. • Medicinal chemicals & botanical products • New York

Rock Creek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:

GREENHUNTER RESOURCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • October 31st, 2014 • GreenHunter Resources, Inc. • Industrial organic chemicals • New York

GREENHUNTER RESOURCES, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

GLOWPOINT, INC.
At Market Issuance Sales Agreement • September 16th, 2014 • Glowpoint, Inc. • Telephone communications (no radiotelephone) • New York
GREENHUNTER RESOURCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 11th, 2014 • GreenHunter Resources, Inc. • Industrial organic chemicals • New York

GREENHUNTER RESOURCES, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 1st, 2014 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York

Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • June 16th, 2014 • Peregrine Pharmaceuticals Inc • Pharmaceutical preparations • Colorado

Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • June 16th, 2014 • Peregrine Pharmaceuticals Inc • Pharmaceutical preparations • Colorado

Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:

AETERNA ZENTARIS INC. Common Shares At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • May 9th, 2014 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York

Aeterna Zentaris Inc. (the “Company”), a corporation formed under the Canada Business Corporations Act (the “CBCA”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • February 18th, 2014 • Cardiome Pharma Corp • Pharmaceutical preparations • New York

Cardiome Pharma Corp. (the “Company”), a corporation formed under the Canada Business Corporations Act (the “CBCA”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

AMERICAN SUPERCONDUCTOR CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • November 18th, 2013 • American Superconductor Corp /De/ • Motors & generators • New York

American Superconductor Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • October 17th, 2013 • Miller Energy Resources, Inc. • Crude petroleum & natural gas • New York

MILLER ENERGY RESOURCES, INC., a Tennessee corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

Common Shares At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • May 21st, 2013 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York

Aeterna Zentaris Inc. (the "Company"), a corporation formed under the Canada Business Corporations Act (the "CBCA"), confirms its agreement (this "Agreement") with MLV & Co. LLC ("MLV"), as follows:

CORONADO BIOSCIENCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • April 29th, 2013 • Coronado Biosciences Inc • Pharmaceutical preparations • New York

Coronado Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • December 28th, 2012 • Peregrine Pharmaceuticals Inc • Pharmaceutical preparations • Colorado

Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with ”)MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:

GREENHUNTER ENERGY, INC. Common Stock (par value $0.001 per share) Preferred Shares (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • December 11th, 2012 • GreenHunter Energy, Inc. • Industrial organic chemicals • New York

GREENHUNTER ENERGY, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

GREENHUNTER ENERGY, INC. Common Stock (par value $0.001 per share) Preferred Shares (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • December 6th, 2012 • GreenHunter Energy, Inc. • Industrial organic chemicals • New York

GREENHUNTER ENERGY, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

ANTHERA PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • November 8th, 2012 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • New York

Anthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

MILLER ENERGY RESOURCES, INC. Common Stock (par value $0.0001 per share) Preferred Stock (par value $0.0001 per share)
At Market Issuance Sales Agreement • October 12th, 2012 • Miller Energy Resources, Inc. • Crude petroleum & natural gas • New York

MILLER ENERGY RESOURCES, INC., a Tennessee corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • October 2nd, 2012 • Novavax Inc • Biological products, (no disgnostic substances) • New York

Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:

ACELRX PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 31st, 2012 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations • New York

AcelRx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

GREENHUNTER ENERGY, INC. Common Stock (par value $0.001 per share) Preferred Shares (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 14th, 2012 • GreenHunter Renewable Power, LLC • Industrial organic chemicals • New York

GREENHUNTER ENERGY, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

FIELDPOINT PETROLEUM CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • May 17th, 2012 • Fieldpoint Petroleum Corp • Crude petroleum & natural gas • New York
ECHO THERAPEUTICS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • May 10th, 2012 • Echo Therapeutics, Inc. • Electromedical & electrotherapeutic apparatus • New York

Echo Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

COMPLETE GENOMICS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • March 12th, 2012 • Complete Genomics Inc • Services-commercial physical & biological research • New York

Complete Genomics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:

At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • February 10th, 2012 • Transwitch Corp /De • Semiconductors & related devices • New York

TranSwitch Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

WAVE SYSTEMS CORP. Class A Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • January 30th, 2012 • Wave Systems Corp • Computer peripheral equipment, nec • New York

Wave Systems Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:

Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • September 30th, 2011 • Us Geothermal Inc • Electric services • New York
MIDWAY GOLD CORP. Common Shares At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • September 26th, 2011 • Midway Gold Corp • Gold and silver ores • New York

Midway Gold Corp., a corporation organized and existing under the laws of British Columbia (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (the “MLV”), as follows:

TELIK, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 31st, 2011 • Telik Inc • Pharmaceutical preparations • New York

Telik, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (the “MLV”), as follows:

BEACON POWER CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • August 24th, 2011 • Beacon Power Corp • Electric services • New York

Beacon Power Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: